Catherine C. Turkel
Board Member
Lexaria Bioscience Corp. (LEXX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Catherine C. Turkel
Catherine C. Turkel is recorded as Board Member at Lexaria Bioscience Corp. (LEXX). Lexaria Bioscience Corp. reported in an 8-K filed September 2, 2022 that Catherine C. Turkel was appointed independent director, effective September 2, 2022.
“On September 2, 2022 (the “Effective Date”) the board of directors of Lexaria Bioscience Corp., in accordance with Nevada corporate laws, increased the size of the board to six members and appointed Catherine C. Turkel, PharmD, PhD as an additional independent director to hold such position until the next shareholder’s meeting.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-09-02–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lexaria Bioscience Corp.
Other people whose current roles at this company are on record from its filings.
- Richard Christopher CEO, Board Member
- Christopher Bunka Chairman
- Michael Shankman CFO
- Nelson Cabatuan CFO
- Al Reese Board Member
- Albert Reese Jr Board Member
- Bal Bhullar Board Member
- Chris Bunka Board Member
- John Docherty Board Member
- Nicholas Baxter Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.